Zoetis grants 81K RSUs to CFO & COO Saccaro

Zoetis granted 81,063 RSUs to its EVP, CFO & COO James Saccaro as part of equity compensation with three-year, time-based vesting conditions.

Rhea-AI Filing Summary

Zoetis Inc. (symbol: ZTS) is the issuer of record for a Form 4 filing submitted to the SEC. SACCARO JAMES reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. (ZTS) reported that EVP, CFO & COO James Saccaro received a compensation-related grant of 81,063 Restricted Stock Units (RSUs) on August 31, 2026. Each RSU represents a contingent right to one share of Zoetis common stock, with one-third scheduled to vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting conditions.

Insider Trade Summary

Grant/Award: 81,063 shares

Grant/Award 1 txn

Insider SACCARO JAMES

Role EVP, CFO & COO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1, F2, F3, F4	81,063	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 81,063 contracts (Direct)

Footnotes (4)

1. F1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. F2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
3. F3. One-third of the total number of RSUs will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, August 31, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Notwithstanding the foregoing, if the Reporting Person's employment with the Company is terminated without Cause (as defined in the Zoetis Executive Severance Plan) prior to the first vesting date, one-third of the RSUs will accelerate and vest as of the date of such termination and will be settled in accordance with the applicable award agreement.
4. F4. Not applicable.

Key Figures

RSUs granted: 81,063 units Underlying common shares: 81,063 shares Post-grant RSU holdings: 81,063 units +2 more

5 metrics

RSUs granted 81,063 units Restricted Stock Units granted to EVP, CFO & COO James Saccaro on August 31, 2026

Underlying common shares 81,063 shares Each RSU represents a contingent right to one share of Zoetis common stock

Post-grant RSU holdings 81,063 units Total RSUs directly held by the reporting person following the reported grant

Vesting schedule tranches 1/3 on each of three anniversaries Three equal installments on the first, second and third anniversaries of the August 31, 2026 grant date

Transaction price per unit $0.00 per unit Equity grant awarded at no cash cost to the executive

Key Terms

Restricted Stock Unit, dividend equivalent units, contingent right, vest, +1 more

5 terms

Restricted Stock Unit financial

"Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

dividend equivalent units financial

"and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs")"

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

contingent right financial

"Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock"

vest financial

"One-third of the total number of RSUs will vest and be settled in shares of Zoetis Inc. common stock"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Cause regulatory

"terminated without Cause (as defined in the Zoetis Executive Severance Plan) prior to the first vesting date"

FAQ

What equity award did Zoetis (ZTS) grant to James Saccaro?

Zoetis granted 81,063 Restricted Stock Units (RSUs) to EVP, CFO & COO James Saccaro on August 31, 2026, representing a potential equivalent number of Zoetis common shares, subject to vesting conditions.

How do the new RSUs for Zoetis (ZTS) executive James Saccaro vest?

The filing states that one-third of the 81,063 RSUs will vest and be settled in Zoetis common stock on each of the first, second and third anniversaries of the August 31, 2026 grant date, subject to continued service and certain earlier-vesting events.

What does each RSU granted by Zoetis (ZTS) to James Saccaro represent?

Each RSU granted to James Saccaro represents a contingent right to receive one share of Zoetis Inc. common stock, including RSUs attributable to dividend equivalent units issued on the award.

Are there acceleration provisions for the Zoetis (ZTS) RSUs granted to James Saccaro?

Yes. If James Saccaro’s employment is terminated without Cause before the first vesting date, one-third of the RSUs will accelerate and vest as of the termination date, with settlement governed by the applicable award agreement.

Was the Zoetis (ZTS) RSU grant to James Saccaro made under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed for this transaction, and no footnote describes it as made under a 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:35 PM Accepted by SEC EDGAR 09/02/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACCARO JAMES

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NEW JERSEY 07054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	(2)	08/31/2026		A		81,063		(3)	(4)	Common Stock	81,063	$0	81,063	D

Explanation of Responses:

1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

3. One-third of the total number of RSUs will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, August 31, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Notwithstanding the foregoing, if the Reporting Person's employment with the Company is terminated without Cause (as defined in the Zoetis Executive Severance Plan) prior to the first vesting date, one-third of the RSUs will accelerate and vest as of the date of such termination and will be settled in accordance with the applicable award agreement.

4. Not applicable.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)